Pilot trial to evaluate immune response using idiotype vaccines following high-dose chemotherapy and hematopoietic stem cell transplantation for follicular lymphoma.

Trial Profile

Pilot trial to evaluate immune response using idiotype vaccines following high-dose chemotherapy and hematopoietic stem cell transplantation for follicular lymphoma.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2011

At a glance

  • Drugs B cell lymphoma vaccine; Keyhole limpet haemocyanin; Sargramostim
  • Indications Follicular lymphoma
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Sep 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 16 Apr 2008 Status changed from recruiting to in progress, as reported in Clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top